TechForce Robotics Unveils Proprietary Beverage Robotics Platform Designed to Increase Revenue and Maximize High-Volume Venue Throughput

(Other OTC:NGTF),(OTC US:NGTF), Los Angeles, CA, Dec. 22, 2025 (GLOBE NEWSWIRE) — via IBN — Nightfood Holdings, Inc. dba TechForce Robotics (OTCQB: NGTF) (“TechForce” or the “Company”), an AI-driven service-robotics platform focused on hospitality, foodservice, and commercial automation, today announces the development and pending launch of a new proprietary beverage dispensing robotic system. The new […]

La Rosa Holdings Corp. Reports 31% Annualized Rate Reduction in Technology Costs in 2025 compared to 2022 Through Proprietary Platform Strategy

(NASDAQ:LRHC), Celebration, FL, Dec. 22, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced a 31% annualized rate reduction in select technology operating costs to date, decreasing from approximately $0.52 million in 2022 to $0.17 million in 2025 resulting in a

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112(TM)) in Autoimmune Diseases and Hematologic Malignancies

(NasdaqGM:CRSP), -Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy data suggest significant clinical improvement in patients dosed at the 100 million cell dose, with the first systemic lupus erythematosus (SLE) patient achieving Definitions of Remission in SLE (DORIS) remission through Month 6- -An additional Phase

KULR Technology Group Announces Six-Month Pause on At-the-Market Equity Offering Program

(NYSE MKT:KULR), HOUSTON , Dec. 22, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery systems for space and defense programs, hyperscale AI data centers, and telecom infrastructure OEMs, today announced that it has elected

EdgeMode Secure Strategic Power Milestone for Europe’s Largest AI Data Center Pipeline

(Other OTC:EDGM),(OTC US:EDGM), FORT LAUDERDALE, Fla., Dec. 22, 2025 (GLOBE NEWSWIRE) — EdgeMode (OTC: EDGM), a global Energy and AI data center infrastructure company, in a joint venture with Blackberry Alternative Investment Fund (BAIF), has announced a major operational milestone in the development of their large-scale AI data center platform in Spain: the necessary power

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

(NASDAQ:FMST),(CNSX:FAT.CN),(NASDAQ:FMSTW),(Frankfurt:F0R),(Frankfurt:F0R.F), VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce its plans for a $9 million exploration program in 2026 (the “2026 Exploration Program“), primarily focused on advancing its Athabasca Basin uranium projects. The Company maintains a portfolio of

Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy

BOSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced the successful dosing of the first patient in the United States in the TENACITY-01 clinical trial (NCT07070219). The TENACITY-01 trial is evaluating CTD402, Imviva's investigational allogeneic anti-CD7 CAR-T cell therapy, for the treatment of

FLINT Secures $451 million in New Contract Awards and Renewals

(TSX:FLNT), CALGARY, Alberta, Dec. 22, 2025 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company“) (TSX: FLNT) is pleased to announce that since the release of its third quarter results and the press release of October 28, 2025 announcing new contract awards and renewals that were estimated to generate approximately $320 million in backlog, FLINT

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NASDAQ:CVRX), MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14,

Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NYSE:IR), DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial officer, and Scott Watson, senior vice president and general manager, Life Science Technologies, will present

Scroll to Top